XENE filings
Corporate insider profile
Ian Mortimer Filing Activity
Latest reported as PRESIDENT & CEO of Xenon Pharmaceuticals Inc. (XENE).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $1,121,400
- Latest transaction
- Sep 30, 2026
Affiliated corporations
Reported company relationships
Transaction history
